Trials / Completed
CompletedNCT00848536
Efficacy Study of Travoprost APS Versus TRAVATAN
A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 371 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Multi-Center Double-masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN in Patients with Open-angle Glaucoma or Ocular Hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost 0.004% (POLYQUAD-preserved) Eye Drops, Solution | One drop once daily in the evening for 3 months |
| DRUG | Travoprost 0.004% (BAK-preserved) Eye Drops, Solution | One drop once daily in the evening for 3 months |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-02-20
- Last updated
- 2012-04-06
- Results posted
- 2011-03-08
Source: ClinicalTrials.gov record NCT00848536. Inclusion in this directory is not an endorsement.